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Traditional approaches to pathological diagnosis include
macroscopic examination and formalin fixation with the pre-
paration of paraffin sections stained with a variety of histo-
chemical techniques. These routine approaches however may
be disappointing in the assessment of many conditions and
occasionally fail to render a precise diagnosis or provide
adequate prognostic information.
Consequently there has been growing interest within the
histopathological community in the state of the nucleus,
DNA and proliferation markers. One of the most recent
produces of this interst is the study of Nucleolar Organiser
Regions (NORs) using a simple silver reduction technique
(AgNOR method).
Nucleolar organiser regions are an essential part of the
machinery of the nucleolus (Howell, 1982; Derenzini et al.,
1983). They can be seen as electron lucent areas at the
ultrastructural level (fibrillar centres) which are the inter-
phase equivalent of the condensed chromosomal NORs (Jor-
dan & McGovern, 1981; Hernandez-Verdun, 1986). These
structures can be seen at the light microscope level using a
variety of techniques including the AgNOR method (Hsu et
al., 1975; Ploton et al., 1986). They are involved in ribo-
some production and potentially qualitative or quantitative
changes in interphase NORs may be visible in relation to
proliferative activity or transformation and could aid diag-
nosis or prognostication.
Physiology and theoretical basis
Mammalian nucleoli have three substructures named accord-
ing to their ultrastructural appearances (Scheer & Benevente,
1990). These comprise (1) the fibrillar centre, (2) the dense
fibrillar component, (3) the granular component. The fibrillar
centre is probably the site where the primary r-RNA tran-
script is generated and contains ribosomal DNA, RNA poly-
merase I and topoisomerase I(a). It is the equivalent of the
interphase NOR seen at the light microscopic level. The
dense fibrillar component is the proposed site of early pro-
cessing of the rRNA precursor and stains with antibodies to
fibrillarin, a protein associated with the U3 small nuclear
ribonucleoprotein (SnRNP) (Scheer & Benevente, 1990). The
granular component is composed of ribosome precursor par-
ticles (Scheer & Benevente, 1990). Experiments in Drosophila
(Karpen et al., 1988) have shown that the nucleolus can form
anywhere an active ribosomal gene is located and the central
element upon which nucleolar structures assemble is the
tandemly-repeated ribosomal DNA that codes for the large
rRNA precursor. Evidence is accumulating that vertebrates
and possibly many other eukaryotes have a common arrange-
ment of regulatory elements that are arranged as two tran-
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scription units per tandem repeat unit (Reeder, 1989). Both
of these are transcribed by RNA polymerase I. The second
polymerase I transcription unit is thought to influence enhan-
cer function (Reeder, 1989). RNA polymerase I transcription
is regulated by at least three polypeptide trans-acting factors:
UBF and a member of the SLI class which probably act as
components of a step where polymerase recognises a stable
complex and initiates transcription, and an initiation factor
that associates tightly with the polymerase but which can be
separated from it (Cavanaugh & Thompson, 1985). Termina-
tion ofpolymerase I transcription requires specific interaction
between the polymerase and a terminator protein (Kuhn et
al., 1990). The large RNAs of ribosomes are initially tran-
scribed as single precursor molecules and then processed in a
complex series of steps to the mature 18S, 58S and 28S
RNAs of functional and ribosomes. This process appears to
be directed by SnRNPs. The most abundant nucleolar
SnRNP contains RNA, U3, fibrillarin (B36) and at least
other six proteins (Parker & Steitz, 1987).
As the rRNA is transcribed and processed it assembles
with a large number of specific proteins, the function of most
of which is structural. Other proteins do not finally appear in
mature ribosomes and have roles in maturation, packaging
and transport. One such protein is nucleolin (C23 protein)
which is localised in the fibrillar centre and dense fibrillar
component. Nucleolin binds to nucleic acids in general,
shuttles between cytoplasm and nucleus and has been implic-
ated in the regulation of RNA polymerase I (Borer &
Lehner, 1989). Other proteins such as N038 (B23 protein,
numatrin) are also associated with the fibrillar centre (NOR)
and may have similar transport functions.
NORs vary in size and shape according to nucleolar trans-
cription. They are intimately related to the cell cycle
(Goessens et al., 1987), and may be related to proliferation or
ploidy in some circumstances (Suresh et al., 1990; Derenzini
et al., 1989; Leek et al., 1990). During prophase the com-
ponents ofthe fibrillar centre disperse and in metaphase these
structures exist in constant positions on the short arms of the
five acrocentric chromosomes (namely 13, 14, 15, 21 and 22).
In telophase, tiny granules associate with these NOR bearing
chromosomes and these are ultimately rearranged into nucle-
olar structures. The precise arrangement of chromosomes
within these nucleolar structures is not known but it is
evident that no clear relationship exists between ploidy and
the numbers of NORs at the light and electron microscope
levels (Mirre & Knibiehler, 1982).
Since NORs occur in pairs (one on each daughter chroma-
tid) on the five acrocentric chromosomes potentially 20 could
be seen at metaphase. However this is a very transient
phenomenon and ten can generally be regarded as a full
complement in diploid cells. Furthermore the acrocentric
chromosomes tend to associate through the satellite regions
and this tendancy has a major influence on the number of
NORs/fibrillar centres observed. Rearrangements and ampli-
fication of the NOR sites have been demonstrated in certain
cell lines (Crossen & Godwin, 1985), and regulatory effects of
hormones on transcription have been observed (DeCapoa et
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al., 1985). There is good evidence that differentiation per se
affects the numbers of NORs observed (Reeves et al., 1984;
Edward et al., 1991) but in general the level of cell prolifera-
tion as measured by several methods, including DNA flow,
cytometry and immunocytochemistry appears to have the
major influence (Derenzine et al., 1989; Trere et al., 1989).
Ploidy, as assessed by DNA flow cytometry or karyotypic
analysis, has little or no effect on interphase NOR scores.
It is clear therefore that ribosomal RNA production is
complex and requires numerous enzymes, transcription fac-
tors, nuclear RNA, and regulatory factors. These combine to
form substructures visible within the nucleolus. The sites
of ribosomal transcription can be visualised by a variety
of techniques directed against the associated proteins
(NORAPS) (Table I). These latter are related specifically to
the transcriptionally active sites (Ferraro & Lavia, 1983),
although the true NOR, that is, rDNA, was originally identi-
fied using radiolabelled rRNA. Some NORAPs notably
nucleolin have been shown to stain preferentially with silver
as a result of their high electron charge density (Williams et
al., 1982), and by virtue of their phosphate (Satoh & Busch,
1981) carboxyl (Olert et al., 1979) and -SH and -s-s-sulphur
moeities (Buys & Osinga, 1980).
The silver reduction technique described below has found
acceptance as a simple and precise method of NOR demon-
stration ideally suited to the investigation of NORs at both
light and electron microscope levels.
The argyrophil (AgNOR) method
In brief, the one step method consists of mixing silver nitrate
and formic acid in optimal proportions with gelatin as a
colloid stabliser. Paraffin or frozen sections are incubated in
this mixture for variable periods (up to 1 h) and then washed
and mounted (Ploton et al., 1986). Ultrastructural and light
microscope studies have indicated that this method is re-
markably specific as a means for the detection of metaphase
and interphase NORs by virtue of their associated proteins.
Indeed, sequential staining with radiolabelled rRNA and
rDNA has shown correspondence between the binding sites
and silver stained NORs on chromosomes and in interphase
nucleoli (Hsu et al., 1975).
The silver reaction product is seen as discrete black dots at
the light microscope level and these can be enumerated using
a x 100 oil immersion lens. Counts in 100 cells are usually
made and the results expressed as the mean number of NORs
per nucleus. The counts are, of course, not absolute since the
NORs themselves are small compared with section thickness.
Staining may have to be adjusted slightly to the individual
silver binding characteristics of each tissue block and internal
controls such as lymphocytes (which have one interphase
NOR) are usually employed. With minor modification the
technique can be used with success with automatic and semi-
automatic image analysis hardware, the total amount of
argyrophil material per nucleus being measured, rather than
the number of sites counted (Ruschoff et al., 1989; Ruschoff
et al., 1990). The one step method (Howell & Black, 1980), is
an ingenious modification of the more time consuming
original three step technique and has itself undergone modi-
fication including preincubation with glycine to reduce incu-
bation time (Cromie et al., 1988), the use of polyethylene
glyco as a protective colloidal developer (in place of gelatin),
to reduce non-specific deposit (Rowlands et al., 1990), and
the inclusion of a celloidin film, also to reduce nonspecific
Table I Techniques for demonstration of NORs
Reagent Target
Radiolabelled rRNA rDNA
Silver colloid (AgNOR) NORAPs
Mercuridibromfluorescein NORAPs
Bismuth ions 100k NORAP
Antibodies Various NORAP epitopes
deposit (Chiu et al., 1989). Furthermore, minor adaptations
have been employed to allow application to cell imprints
(Boldy et al., 1989; Ruschoff et al., 1989), cytospin prepara-
tions (Ruschoff et al., 1989), and semithin methacrylate sec-
tions (Moreno et al., 1989).
Technical aspects
The one step silver method appears to give reproducible and
specific staining results (Hernandez-Verdun et al., 1980; Buys
& Osinga, 1980; Ochs & Busch, 1984). From the early stages
however, it was clear that uniformity with respect to fixation,
technique and enumeration were required to optimise consis-
tent discrimination of silver stained NORs (AgNORs).
In general, prompt fixation in 10% formol saline is perfect-
ly satisfactory (Crocker et al., 1989; Smith et al., 1988).
Alcoholic fixatives may give stronger staining, but picric
acid- and mercury-containing fiixatives are highly deleterious
(Smith et al., 1988). The technique is readily applicable to
microwave fixed tissue (Leong & Raymond, 1988), and
frozen sections (Murray et al., 1989), furthermore sequential
staining with immunohistochemical reagents has no adverse
effects (Murray et al., 1989). The latter may be most useful
where neoplasms are highly heterogeneous, the immunohisto-
chemical method being used to pinpoint (or exclude) the cells
in which AgNOR enumeration is required.
Early studies counted all separate silver stained structures
after a constant incubation time but it is now clear that
minor alterations according to internal controls are advisable
to allow counting of subsiduary dots within nucleolar asso-
ciations (Crocker et al., 1989; Ruschoff & Plate, 1990). This
recent drive to uniformity has obviated certain early work
and further studies are currently underway.
Application
The potential of the one step silver colloid technique is
histopathology was first investigated by Ploton et al. (1986)
who stained an unspecified number of specimens of prostate
and concluded that the method might prove useful in tumour
diagnosis.
Numerous studies have subsequently appeared in the liter-
ature investigating malignancy, borderline malignancy and a
variety of non neoplastic conditions. These are discussed
below and conditions in which AgNORs may be of diagnos-
tic or prognostic use are summarised in Table II.
Malignant conditions - lymphoma
The potential of AgNOR identification and quantification
has been investigated in the greatest detail in lymphomas.
The assessment and grading of non Hodgkin's lymphoma
(NHL) is a clinically crucial procedure and accurate evalua-
Table IIa Situations in which histological evaluation of AgNORs
provide information additional to traditional histopathological
methods
Lymphoma grading Islet cell neoplasms
Pleural malignancy Small cell tumours of childhood
Small cell carcinoma of lung Infantile fibrosarcoma
Cholesteatoma Gliomas
In situ carcinoma of the testis Hepatocellular carcinomas
Borderline serous tumours of Rejection of renal allografts
ovary
Table IIB Conditions in which histological evaluation of AgNORs
appear to be of prognostic value
Colonic neoplasia Neuroblastoma
Gastric cancer Mast cell tumours
? Breast cancer
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tion currently requires a battery of special procedures includ-
ing light and electron microscopy, immunohistochemistry,
histochemistry and DNA technology. It would not appear
that NOR enumeration is of value in the study of NHL in
both sections (Crocker & Nar, 1987), and cell imprints
(Boldy et al., 1989) and also in the related field of bone
marrow aspirate evaluation (Nikicicz & Norback, 1990).
Initial studies have indicated that enumeration (Boldy et
al., 1989) or even morphometric analysis of the size of fibril-
lar centres (Crocker & Egan, 1989; Goodlad et al., 1991) can
help in the identification of high from low grade types. Two
further studies of follicular lymphoma have shown that when
used alone AgNORs cannot distinguish follicular hyperplasia
from this distinct subtype of low grade lymphoma (Cronin et
al., 1989; Cibull et al., 1989).
Subsequent studies have shown that the number of
AgNORS observed are closely related to the percentage of
cells recognised by the antibody Ki 67 (Hall et al., 1987).
This antibody binds to a nuclear antigen expressed in all cell
cycle phases except G. Furthermore, in lymphomas, AgNOR
numbers show no relationship to ploidy as assessed by DNA
flow cytometry (Crocker et al., 1988), or numbers of
AgNORs or chromosomes themselves observed in metaphase
spreads (Janmohamed et al., 1989), but have a close correla-
tion with the percentage S phase cells (Crocker et al., 1988)
as determined by DNA flow cytometry. It is likely therefore
that sizes and numbers of AgNORs are dependent on the
proliferative status of the cell or tissue studied.
Gastrointestinal tract
Several studies of rectal and colonic neoplasia have failed to
demonstrate the value of evaluation of AgNORs with regard
to clinical outcome (Griffiths et al., 1989; Arends & Kate,
1988; Tildsley et al., 1990). Other studies have discriminated
accurately between benign and malignant conditions and
demonstrated prognostic significance (Ruschoff & Plate,
1990; Young et al., 1990; Ofner et al., 1990; Ruschoff et al.,
1990; Derenzini et al., 1991). This apparent contrast may be
explicable by incubation time alone. In the former studies,
long incubation times may have caused overstaining and led
to false fusion of AgNORs lending to decreased scores. It
would therefore appear that athough AgNORs have no real
advantage over established techniques in the diagnosis of
colonic cancer, when used in the assessment of prognosis
they may have considerable utility.
Using AgNOR scores as markers of proliferative activity
in gastric epithelium Rosa et al. (Mehta & Filipe, 1990a)
have demonstrated significant differences between dysplastic,
malignant and normal epithelium. As in lymphoma this
group subsequently showed no relationship between AgNOR
counts and DNA index (Rosa et al., 1990b; Ruschoff &
Plate, 1990). Ruschoff et al. demonstrated a prognostic signi-
ficance in gastric carcinoma. Early studies using longer but
variable incubation times showed overlap between benign,
regenerative and malignant epithelium (Suarez et al., 1989).
Respiratory tract
Studies of pulmonary tumours have also yielded confficting
results, once again explicable on the basis of the technique
employed. We have found AgNOR enumeration to be useful
in the evaluation of malignancy in pleural aspirates, pleural
biopsies and follow-up post mortem tissue (unpublished
observations). The method distinguishes reliably between
malignancy and hyperplasia but cannot differentiate mesothe-
lioma from adenocarcinoma (Ayres et al., 1988). Other works
have found it to be of limited use in this context (Soosay et
al., 1989; Leopardi et al., 1990), but in the opinion of the
authors NOR staining enhances the diagnostic yield, and
provides information additional to that derived from tradit-
ional methods. The method can distinguish small cell carcin-
oma of bronchus from lymphocytes which is particularly
useful in small biopsies (Crocker et al., 1987), but cannot
distinguish carcinoids, atypical carcinoids (Benbow &
Cromie, 1989) or low grade NHL (Crocker et al., 1987).
In other situations the use of AgNOR counts is yet to be
proven. Counts in squamous carcinomas of larynx and bron-
chus are related inversely to differentiation (Ashworth &
Helliwell, 1988; Crocker, 1990); however, squamous tumours
of pharynx and larynx cannot be separated on the basis of
AgNOR counts (Bryan et al., 1990). It is not yet certain
whether AgNORs are related to prognosis for the different
histological varieties of lung cancer and investigation are
currently underway. Studies of AgNORs and therapeutic
response are needed, not only in lung tumours but in many
other contexts.
Breast
In the case of breast disease diagnostic AgNOR studies have
been published which show enumeration to be useful (Smith
& Crocker, 1988; Ohri et al., 1988; Raymond & Leong, 1989)
or of limited value (Giri et al., 1989). Prognostic studies have
indicated that counting and AgNOR morphology may pro-
vide information with regard to nodal metastases, supple-
mentary to that obtained by established methodology (Sividis
& Sims, 1990). Currently there is no indication that AgNOR
enumeration will prove to be of value in the histological
diagnosis of breast lesions, but potentially useful applications
are to cytologically suspect, and equivocal fine needle
aspirate specimens and to prognosis.
Skin
The method is applicable to skin pathology although it does
not appear superior to established methodology. Adnexal
tumours and epidermal tumours can be identified on the
basis of AgNORs and the spectrum of differentiation of
squamous carcinoma is reflected by a range of AgNOR
numbers (Egan & Crocker, 1988). Studies of melanocytic
tumours are hampered by the argyrophilia of melanin
(Crocker & Skilbeck, 1987); nevertheless it has been shown
that AgNOR staining is useful in separating melanocytic
naevi from malignant melanomas (Crocker & Skilbeck, 1987;
Leong & Gilham, 1989; Derenzini et al., 1986) but of limited
value as a prognostic indicator (Howat et al., 1988). The
value of NOR staining in borderline lesions is currently
uncertain (Fallowfield et al., 1988; Fallowfield & Cook, 1989;
Howat & Giri, 1989). Indeed the very existance of dysplastic
naevi as a clinical and pathological entity is a matter of
considerable debate (Clark et al., 1984; Ackerman, 1988).
The only studies of AgNORs in dysplastic naevi suffer from
the same overstaining as other earlier AgNOR studies and
consequently may have a limited contribution (Fallowfield et
al., 1988; Fallowfield & Cook, 1989). Differentiation of
melanoma cell lines under the influence of retinoic acid is
associated with a reversible decrease in the number of
AgNORs (Youngshan & Stanley, 1988). No clinical chemo-
therapeutic response studies are available.
Genitourinary system
The diagnosis and grading of renal carcinoma using evalua-
tion of AgNORs by light microscopy or image analysis has
been shown to be of great value and readily applicable to
cytological specimens (Ruschoff et al., 1989). The diagnosis
of in situ carcinoma of the testis can be made using AgNOR
counts (Loftus et al., 1988) and spermatic seminoma and
typical seminoma showed different distributions of AgNORs
(Delahunt et al., 1990). AgNOR analysis in prostatic adeno-
carcinomas has considerable prognostic utility (Contractor et
al., 1989). Significant differences of AgNOR counts are seen
for pathological endometrium and neoplastic endometrium
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case is limited (Hansen & Ostergard, 1990; Coumbe et at.,
1988). In non neoplastic trophoblastic tissue AgNOR counts
reflect ploidy and not proliferation (Suresh et al., 1990), thus
apparently being unique in tissues so far studied; the reason
for this is obscure. AgNOR counts may be useful in the
diagnosis of borderline serous tumours of ovary but not in
mucinous tumours (Griffiths et al., 1989; Kinsey et al., 1988;
Mauri et al., 1990). Studies of ectocervical and endocervical
tissue have to date used long incubation times and have
utilised NOR aggregates as single counts. Repeat studies are
underway but nevertheless useful data have been obtained.
Cervical intraepithelial neoplasia (CIN) shows a progressive
increase in numbers of AgNORs with diminishing size from
CINI to CIN3 (Egan et al., 1988; Egan et al., 1990). Altered
nucleolar organisation and AgNOR counts are present in
cervical intraepithelial glandular neoplasia (adenocarcinoma
in situ, CIGN) (Wood & Egan, 1989) with a spectrum from
in situ to invasive disease (Darne et al., 1990). This suggests
that CIGN is a premalignant precursor. Additionally, altera-
tion of AgNOR numbers and distribution adjacent to
morphological CIGN ('field changes'), not visible in conven-
tional section have been reported as being both absent (Culli-
more et al., 1989) and present (Darne et al., 1990). Yet again,
differing methods of staining and enumeration may account
for this discrepancy.
Endocrine tumours
AgNOR numbers are of limited value in the diagnostic
assessment of thyroid neoplasms (Nairn et al., 1988) and
certain neuroendocrine neoplasms (Benbow & Cromie, 1989)
but appear useful in the assessment of pituitary adenomas
(McNichol et al., 1988) and islet cell neoplasms (Ruschof et
al., 1991).
Paediatric tumours
Certain childhood tumours have been studied. Fibrosarcoma
can be differentiated from fibrous proliferations (Egan et al.,
1988a) and neuroblastoma can be differentiated from other
small round cell tumours on the basis of AgNOR counts
(Egan et al., 1987). AgNOR numbers are strongly correlated
with histopathological prognostic indices of neuroblastoma
and are an independent prognostic indicator in that condi-
tion (Egan et al., 1988b). The series of rhabdomyosarcoma
and Ewings sarcoma reported was too small to fully assess
prognostic utility (Egan et al., 1988c; Egan et al., 1988d).
Experimental studies of neuroblastoma cell lines have shown
a strict relationship between doubling time and AgNOR
numbers and no clear relationship with synthetic activity or
karyotype (Derenzini et al., 1989); indeed, this investigation
was seminal in our understanding of AgNOR counts to
proliferation. The strict relationship could explain the higher
quantity of interphasic NOR which has been repeatedly
shown in malignant tumour cells in comparison with the
corresponding benign lesions. Cancers are in fact character-
ised by a tissue growth rate almost always faster than benign
or hyperplastic lesions.
Ear, nose and throat tumours
AgNORs have radically altered the diagnosis of cholestea-
toma which cannot reliably be made by any other light
microscopic method (Cooper & Micheals, 1989). Malignant
transitional cell tumours of the nose can be diagnosed using
the AgNOR method (Egan et al., 1988) and early results
from prospective studies have shown that recurrent benign
transitional papillomas have a significantly increased number
of AgNORs. Benign and malignant salivary neoplasms can
be identified by semiquantitative assessment of silver stained
NORs (Morgan et al., 1988).
CNS tumours
Enumeration is useful in the diagnosis of meningiomas
(Satoh & Busch, 1981) but appears unable to predict their
biological behaviour (Boon & Sharif, 1988). Gliomas and
gliosis can be differentiated using AgNORs (Crocker, 1990)
but the diagnosis and prediction of behaviour of occular
melanomas is not enhanced by their evaluation (Williams et
al., 1988).
Other
NORs are of predictive value in canine mast cell tumours
and superior to established prognostic indices (Bostock et al.,
1989).
Borderline lesions
A continuum of AgNOR numbers is seen in dysplastic laryn-
geal epithelium (Ashworth & Helliwell, 1988; Crocker, 1990),
dysplastic bronchial epithelium and CIN (Egan et al., 1988;
Egan et al., 1990; Rowlands, 1988). In situ transitional car-
cinoma of the nose can be distinguished from benign and
invasive disease (Egan et al., 1988). In situ disease of the
testis (Loftus et al., 1988; Delahunt et al., 1990) and endo-
cervix (Wood & Egan, 1989) can be identified and the techni-
que may be of value in the assessment of borderline serous
tumours of ovary (Griffiths et al., 1989) and atypical endo-
metrial hyperplasia (Coumbe et al., 1988).
Prospective studies of cirrhosis, normal liver and hepato-
cellular carcinoma showed that AgNOR numbers were
predictive in those cases which light microscopy could not
distinguish (Crocker & McGovern, 1988).
Non-neoplastic lesions
AgNORs are a sensitive indicator of tubular damage and
degree of recovery in renal allografts (Dodd et al., 1988), a
phenomenon which may be hard to assess with conventional
methods. A physiological increase in AgNORs is seen in rat
pituitary corticotrophs following adrenalectomy (Peebles &
McNichol, 1988), and the diagnosis of several benign condi-
tions can be enhanced and malignancy excluded for example
renal xanthogranuloma (Bryan & Crocker, 1989), cirrhosis of
the liver (Crocker & McGovern, 1988).
Conclusions
Currently on the basis ofpublished data it would appear that
AgNORs can enhance the diagnostic yield in a number of
defined situations. In cholesteotoma it is vastly superior to
established methods, but in all other situations the inform-
ation provided is complimentary to traditional techniques. A
recent drive to uniformity has increased the utility of an
already reproducible method and will enable further elucida-
tion of the natue of AgNORs. Staining and enumeration is
however exacting and inexperience in both can cause poor,
uninterpretable or false results. Consequently the place of
AgNORs in busy routine laboratories who would carry out
the technique intermittently is limited but in certain situa-
tions the information provided is indispensible and the results
rewarding.
Prospective studies currently underway should define fur-
ther the prognostic utility of the technique. Overstaining may
in the past have contributed to nucleolar rather than NOR
staining and diminished confidence in the method but current
indications are that when used properly the method is a
valuable tool and that the initial promise documented above
will continue to find applications in numerous fields of
research and diagnosis.NUCLEOLAR ORGANISER REGIONS IN PATHOLOGY 5
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